SC
NEO icon

Samlyn Capital’s NeoGenomics NEO Stock Holding History

Samlyn Capital’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.1M Sell
2,131,337
-426,012
-17% -$4.11M 0.51% 58
2026
Q1 		$19M Buy
2,557,349
+1,169,128
+84% +$12.3M 0.32% 66
2025
Q4 		$16.3M Buy
+1,388,221
New +$15M 0.26% 68

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Samlyn Capital's NEO Position: Q2 2026 in Review

Samlyn Capital reduced its NeoGenomics (NEO) stake by 17% in Q2 2026, selling an estimated $4.11M and leaving 2,131,337 shares worth $31.1M. The position accounts for 0.51% of the portfolio, ranked #58.

Samlyn Capital first reported a position in NEO in Q4 2025 and has held it in 3 quarters since. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Samlyn Capital held 2,131,337 shares of NeoGenomics worth $31.1M as of Q2 2026.
  • Samlyn Capital sold 426,012 NeoGenomics shares in Q2 2026, an estimated $4.11M.
  • NeoGenomics made up 0.51% of Samlyn Capital's portfolio in Q2 2026, its #58 holding.
  • Samlyn Capital first reported a position in NeoGenomics in Q4 2025 and has held it in 3 quarters since.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Samlyn Capital's 13F filing for Q2 2026, filed 14 Aug 2026.